| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 2A1-01-10381 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2A1-02-10382 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2A2-01-10383 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2A2-02-10384 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2B1-01-10385 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2B1-02-10386 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2B2-01-10387 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2B2-02-10388 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2B3-01-10389 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 2B3-02-10390 | Treatment:5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 1A1-01-10368 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1A1-02-10369 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1A2-01-10370 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1A2-02-10371 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1A3-01-10372 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1A3-02-10373 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1B1-01-10374 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1B1-02-10375 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1B2-01-10376 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1B2-02-10377 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1B3-01-10378 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 1B3-02-10379 | Treatment:Doxorubicin | AU |
| Reversed phase POSITIVE ION MODE | 3A1-01-10392 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3A1-02-10393 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3A2-01-10394 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3A2-02-10395 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3B1-01-10396 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3B1-02-10397 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3B2-01-10398 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3B2-02-10399 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3B3-01-10400 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 3B3-02-10401 | Treatment:Doxorubicin + 5-fluorouracil | AU |
| Reversed phase POSITIVE ION MODE | 5A1-01-10416 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5A1-02-10417 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5A2-01-10418 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5A2-02-10419 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5A3-01-10420 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5A3-02-10421 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5B1-01-10422 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5B1-02-10423 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5B2-01-10424 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5B2-02-10425 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5B3-01-10426 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 5B3-02-10427 | Treatment:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | 4A1-01-10403 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4A1-02-10404 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4A2-01-10405 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4A2-02-10406 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4A4-01-10407 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4A4-02-10408 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4B1-01-10409 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4B1-02-10410 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4B2-01-10411 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4B2-02-10412 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4B3-01-10413 | Treatment:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | 4B3-02-10414 | Treatment:Positive Control | AU |
Return to study ST002975 main page
Download data matrix(Metabolomics Insights into Doxorubicin and 5-Fluorouracil Combination Therapy in Triple-Negative Breast Cancer: A Xenograft Model Study (Part 1) Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|